L, S., M, N., N, H., D, S., A, C., & O, M. (2026). Antibody-Drug Conjugates Drug Product Formulation and Process Development, Scalability and Stability Considerations. AAPS PharmSciTech, 27(5), . https://doi.org/10.1208/s12249-026-03457-9
Chicago Style (17th ed.) CitationL, Sorret, Ninomiya M, Hillebrandt N, Schmitt D, Chattopadhyay A, and McGarvey O. "Antibody-Drug Conjugates Drug Product Formulation and Process Development, Scalability and Stability Considerations." AAPS PharmSciTech 27, no. 5 (2026). https://doi.org/10.1208/s12249-026-03457-9.
MLA (9th ed.) CitationL, Sorret, et al. "Antibody-Drug Conjugates Drug Product Formulation and Process Development, Scalability and Stability Considerations." AAPS PharmSciTech, vol. 27, no. 5, 2026, https://doi.org/10.1208/s12249-026-03457-9.